Cervical Dystonia Clinical Trial
Official title:
Deep Brain Stimulation of the Globus Pallidus Interna or the Subthalamic Nucleus for Treatment of Primary Cervical Dystonia
This study will evaluate the effectiveness of deep brain stimulation (DBS) for treating
primary dystonia. Patients with dystonia have muscle spasms that cause uncontrolled twisting
and repetitive movement or abnormal postures. Medical therapies are available, but not all
patients get adequate relief from the abnormal movements or the pain associated with them.
DBS is a surgical procedure that interrupts neuronal circuits in the globus pallidus interna
(Gpi) and subthalamic nucleus (STN) - areas of the basal ganglia of the brain that do not
work correctly in patients with dystonia. This results in decreased movement and therefore
may lessen patients' symptoms and pain. The study will also examine the physiology of
dystonia and determine whether the treatment effects of DBS in the Gpi differ significantly
from DBS of the STN.
Patients 18 years of age and older with primary cervical dystonia that does not respond to
medical treatment or botulinum toxin (Botox) may be eligible for this study. Candidates are
screened with blood and urine tests, chest x-ray, electrocardiogram, and magnetic resonance
imaging (MRI, see below) of the brain.
Each participant undergoes the following tests and procedures:
- Magnetic resonance imaging. This procedure is done after implantation of the
stimulators to verify position of the electrodes. MRI uses a magnetic field and radio
waves to produce images of the brain. The patient lies on a table that is moved into
the scanner (a narrow cylinder), wearing earplugs to muffle loud knocking and thumping
sounds that occur during the scanning process. The procedure usually lasts about 45 to
90 minutes, during which the patient is asked to lie still for up to 15 minutes at a
time.
- Transcranial magnetic stimulation. This procedure maps brain function. A wire coil is
held on the scalp, and a brief electrical current is passed through the coil, creating
a magnetic pulse that stimulates the brain. During the stimulation, the patient may be
asked to tense certain muscles slightly or perform other simple actions. The
stimulation may cause a twitch in muscles of the face, arm, or leg, and the patient may
hear a click and feel a pulling sensation on the skin under the coil. During the
stimulation, electrical activity of muscles is recorded with a computer, using
electrodes attached to the skin with tape.
- Neurologic evaluation. Before and after DBS, the patient's dystonia is measured with a
standardized rating scale called the Toronto Western Spasmodic Torticollis Scale
(TWSTRS).
- DBS treatment. Patients are randomly assigned to have electrodes implanted in either
the Gpi or STN area of the basal ganglia. The electrodes are what stimulate the brain
in DBS therapy. Before surgery, a frame is secured to the patient's head, and an MRI
scan is done. DBS involves making two small incisions and two small holes in the skull,
opening the lining around the brain, locating the Gpi or STN, securing the electrodes
in place, and connecting them to the pulse generator that is placed under the skin
below the collar bone. In addition, during the surgery, the patient is asked to move
certain muscles. The muscle activity is recorded to gain a better understanding of the
physiology of movement. After surgery, MRI scans are done to confirm placement of the
electrodes.
- Stimulation and evaluation. After surgery, patients' movements are evaluated during and
after stimulation. The changes in movement and function are videotaped and scored
according to a rating scale. The optimal stimulation settings are determined and the
stimulators are adjusted accordingly.
Neurologic evaluations with the TWSTRS scale are repeated at 1, 2, 3, 6 and 12 months after
surgery, and the stimulators are adjusted as needed. Some of the evaluations are videotaped.
Objective: For patients with cervical dystonia who have failed medical therapy, stereotactic
deep brain stimulation (DBS) of the globus pallidus interna (Gpi) or subthalamic nucleus
(STN) can provide significant symptom improvement, but it is not known which site provides
maximum benefit or the physiologic mechanisms by which these improvements may occur. The
study goals are to determine if DBS of Gpi or STN provides significant clinical improvement
in patients with primary cervical dystonia, whether the anatomic DBS site (if either)
provides optimal improvement, and to gain deeper insight into the underlying pathophysiology
of this disorder.
Study population: Adult patients with medically refractory primary cervical dystonia will
make-up the study population. Patients with primary cervical dystonia suffer a wide range of
symptoms including physical deformity, speech difficulties, swallowing dysfunction, visual
problems, and intractable pain, which can result in an inability to care for themselves.
Design: We propose placing DBS electrodes (using microelectrode guidance) bilaterally into
either the Gpi or STN of medically refractory cervical dystonia patients. Physiological
studies will be performed and compared with clinical changes to understand the mechanism of
action of DBS and underlying pathophysiology of cervical dystonia.
Outcome measures: Clinical effectiveness of DBS of the Gpi or STN will be measured by the
Toronto Western Spasmodic Torticollis Scale and monitored over time to determine the
effectiveness of DBS and if there is an ideal anatomic stimulation site. Electrophysiologic
outcome measures will be obtained to determine the underlying pathophysiology of cervical
dystonia, and the mechanism of action of DBS.
;
Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03617367 -
Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
|
Phase 3 | |
Not yet recruiting |
NCT04057911 -
A Trial of Non-invasive Stimulation in Cervical Dystonia
|
N/A | |
Withdrawn |
NCT02180139 -
tDCS in Cervical Dystonia
|
N/A | |
Completed |
NCT00541905 -
Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia
|
Phase 4 | |
Unknown status |
NCT00418925 -
Efficacy of Dronabinol for the Treatment of Cervical Dystonia
|
Phase 2 | |
Not yet recruiting |
NCT05715138 -
Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia
|
N/A | |
Completed |
NCT02131467 -
Safety and Tolerability of Perampanel in Cervical Dystonia
|
Phase 1/Phase 2 | |
Completed |
NCT02959645 -
Assessment of Brain Activities in Cervical Dystonia
|
||
Completed |
NCT03805152 -
Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia
|
Phase 3 | |
Completed |
NCT04949594 -
Relief of Pain in Patients With Cervical Dystonia Through the Use of Transcutaneous Electric Nerve Stimulation (TENS)
|
||
Recruiting |
NCT01664013 -
The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients
|
Phase 4 | |
Completed |
NCT00447772 -
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
|
Phase 3 | |
Completed |
NCT00210431 -
Post Marketing Surveillance Study of Dysport
|
||
Completed |
NCT05157100 -
Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia
|
Phase 4 | |
Completed |
NCT00257660 -
Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
|
Phase 3 | |
Completed |
NCT05103202 -
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
|
||
Terminated |
NCT00760318 -
Keppra for Cervical Dystonia
|
Phase 2 | |
Completed |
NCT00323765 -
Plasticity in Cervical Dystonia
|
N/A | |
Completed |
NCT04171258 -
Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia
|
Phase 1 | |
Completed |
NCT04849988 -
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
|
Phase 2 |